BioSpace News Archive

Recently completed Phase 3 RAMSES study confirms safety profile of AR101 in peanut-allergic children and teens

Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET

Conference Call Friday, November 9th at 8:30 a.m. ET

Announced Agreement with Cedars-Sinai Medical Center to Co-fund a Phase 2b Investigator-Sponsored Clinical Study of SYN-010, for the Treatment of IBS-C

All quotes for attribution to National Kidney Foundation (NKF).

Access to healthcare just got a whole lot easier for local shoppers at two Phoenix-area Safeway stores.

DeepRadiology is proud to announce its official winning entry in the international Radiological Society of North America (RSNA) Pneumonia Challenge.

N8 Medical, a clinical-stage biopharmaceutical company focused on developing novel combination medical devices and antifungal and anti-bacterial therapeutics for the prevention and treatment of serious and life-threatening infections, announced today that it appointed David S. Perlin, Ph.D. to its Scientific Advisory Board (SAB).

Gateway Health’s Board of Directors today announced Cain A. Hayes, MBA, CEBS, ChFC as its president and CEO, effective Nov. 26.

It was 1988 when Life Time Founder Bahram Akradi sketched the design for what would become the first Life Time ever built.